Yuki Teramoto - Concepedia

Author

Yuki Teramoto

University of Rochester Medical Center ORCID

Also Known As

Teramoto, Yuki, Y. Teramoto, Yuki Teramoto

114

Publications

876

Citations

H-Index

Concepts

All Affiliations

University of Rochester Medical Center Kyoto University Hospital Kyoto University Johns Hopkins University Johns Hopkins Medicine

About

Yuki Teramoto is an author at University of Rochester Medical Center specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	271
2	Cell Biology	3	3	80
3	Engineering	1	1	145
4	Health Sciences	1	1	13
5	Diabetes	1	1	20

Yuki Teramoto

Publications

553

Citations

H-Index

Page 1

	Year	Citations
Adaptive Weighting Multi-Field-Of-View CNN for Semantic Segmentation in Pathology Hiroki Tokunaga, Yuki Teramoto, Akihiko Yoshizawa, EngineeringMachine LearningImage FeaturesDigital PathologyPathology	2019	145
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies Yuki Kita, Akihiro Hamada, Ryoichi Saito, British Journal of Cancer	2019	59
Divergent Nematic Susceptibility near the Pseudogap Critical Point in a Cuprate Superconductor Kousuke Ishida, S. Hosoi, Yuki Teramoto, Journal of the Physical Society of Japan	2020	52
FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells Hiroki Ide, Taichi Mizushima, Guiyang Jiang, Endocrine Related Cancer Androgen ReceptorUrothelial CellsPathologyAr/erβ SignalsCancer Biology	2020	33
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder Norihiko Masuda, Kaoru Murakami, Yuki Kita, American Journal Of Pathology Tumor BiologyLineage PlasticityGenitourinary CancerMedicineTrp53 Mutation	2020	32
Insulinoma with a History of Epilepsy: Still a Possible Misleading Factor in the Early Diagnosis of Insulinoma Takaaki Murakami, Takafumi Yamashita, Daisuke Yabe, Internal Medicine Early DiagnosisDiabetes ManagementInsulin ManagementDiabetesDelayed Diagnosis	2017	20
Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer Yuki Teramoto, Guiyang Jiang, Takuro Goto, International Journal of Molecular Sciences	2021	20
Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer. Takuro Goto, Eiji Kashiwagi, Guiyang Jiang, PubMed	2020	17
Clinical Significance of Perineural Invasion by Prostate Cancer Detected on Needle Core Biopsy Yuki Teramoto, Numbereye Numbere, Ying Wang, American Journal of Clinical Pathology	2022	16
Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis Masayuki Uegaki, Yuki Kita, Ryutaro Shirakawa, Carcinogenesis Transcriptional RegulationUrologySignaling PathwayMedicineProstate Carcinogenesis	2019	15

Page 1